Tenon Medical, Inc. Stock

Equities

TNON

US88066N2045

Medical Equipment, Supplies & Distribution

Delayed Nasdaq 10:51:54 2024-05-13 am EDT 5-day change 1st Jan Change
0.8744 USD -1.64% Intraday chart for Tenon Medical, Inc. +3.97% -44.66%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 4.85M Sales 2025 * 9.19M Capitalization 3.31M
Net income 2024 * -15M Net income 2025 * -14M EV / Sales 2024 * 0.14 x
Net cash position 2024 * 2.63M Net cash position 2025 * 5.56M EV / Sales 2025 * -0.24 x
P/E ratio 2024 *
-0.28 x
P/E ratio 2025 *
-0.47 x
Employees 21
Yield 2024 *
-
Yield 2025 *
-
Free-Float 89.33%
More Fundamentals * Assessed data
Dynamic Chart
1 day+5.83%
1 week+4.59%
Current month+17.75%
1 month+10.99%
3 months-22.46%
6 months-63.11%
Current year-43.73%
More quotes
1 week
0.80
Extreme 0.8
0.90
1 month
0.71
Extreme 0.71
0.90
Current year
0.71
Extreme 0.71
1.72
1 year
0.71
Extreme 0.71
18.85
3 years
0.71
Extreme 0.71
598.90
5 years
0.71
Extreme 0.71
598.90
10 years
0.71
Extreme 0.71
598.90
More quotes
Managers TitleAgeSince
Founder 58 12-06-18
Chief Executive Officer 56 -
Director of Finance/CFO 69 21-05-31
Members of the board TitleAgeSince
Founder 70 20-11-30
Director/Board Member 64 21-12-31
Director/Board Member 81 21-12-31
More insiders
Date Price Change Volume
24-05-13 0.8744 -1.64% 18 217
24-05-10 0.889 +5.83% 30,629
24-05-09 0.84 -2.33% 7,688
24-05-08 0.86 +1.18% 13,110
24-05-07 0.85 +1.07% 11,330

Delayed Quote Nasdaq, May 10, 2024 at 04:30 pm EDT

More quotes
Tenon Medical, Inc. is a medical device company. The Company has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. The Catamaran System is designed specially to resist vertical shear and rotation of the joint in which it was implanted, helping stabilize the joint in preparation for eventual fusion. The Company has also developed a proprietary two-dimensional (2D) placement protocol as well as a protocol for three-dimensional (3D) navigation utilizing the latest techniques in spine surgery.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.889 USD
Average target price
4.5 USD
Spread / Average Target
+406.19%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW